Cargando…
Patients with Pulmonary Metastases from Head and Neck Cancer Benefit from Pulmonary Metastasectomy, A Systematic Review
Background and Objectives: The incidence of distant metastases in patients with head and neck cancer (HNC) is approximately 10%. Pulmonary metastases are the most frequent distant location, with an incidence of 70–85%. The standard treatment options are chemo-, immuno- and radiotherapy. Despite a be...
Autores principales: | Schlachtenberger, Georg, Doerr, Fabian, Menghesha, Hruy, Lauinger, Patrick, Wolber, Philipp, Sabashnikov, Anton, Popov, Aron-Frederik, Macherey-Meyer, Sascha, Bennink, Gerardus, Klussmann, Jens P., Wahlers, Thorsten, Hekmat, Khosro, Heldwein, Mathias B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332790/ https://www.ncbi.nlm.nih.gov/pubmed/35893115 http://dx.doi.org/10.3390/medicina58081000 |
Ejemplares similares
-
Neoadjuvant chemoimmunotherapy as a potential therapeutic option in NSCLC UICC stage IIIA with multilevel N2 disease
por: Menghesha, Hruy, et al.
Publicado: (2022) -
Stage I and II Small-Cell Lung Cancer—New Challenge for Surgery
por: Doerr, Fabian, et al.
Publicado: (2022) -
Redefining the role of surgery in early small-cell lung cancer
por: Doerr, Fabian, et al.
Publicado: (2022) -
The impact of thymectomy in subgroups of Myasthenia gravis patients: a single center longitudinal observation
por: Menghesha, Hruy, et al.
Publicado: (2023) -
Der Stellenwert der Thymektomie ohne Thymom in der Therapie der Myasthenia gravis
por: Menghesha, Hruy, et al.
Publicado: (2021)